as the effectiveness of continuous azathioprine therapy in multiple sclerosis ( ms ) is still controversial , we have conducted a prospective trial of the drug ( 2 mg/kg daily for at least 2 years ) in patients with clinically definite ms , ie with remitting , remitting-progressive and progressive ms .
C0004482
azathioprine
C0026769
ms